NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Invesco Biotechnology & Genome ETF PBE | AMEX

$98.93 $2.21 | 2.28%
TREND SIGNAL:Signal available — unlock to view |2026-10-15

Company Overview:

Market Cap: $294.87M
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $70.83 - $99.19

10 Year PBE Performance Metrics:

Total Return (with DRIP): 164.5% (10.21% CAGR)
Total Return (no DRIP): 161.9% (10.10% CAGR)
Share Price: 156.2% (9.87% CAGR)
Yield on Cost (with DRIP): 0.20%
Total Invested: $10,000
Total Value (with DRIP): $26,447
Total Return $ (with DRIP): $16,447
Dividend Increase: 171.1% (10.75% CAGR)
Dividend Yield (FWD): 0.08% ($0.08)
PBE 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
PBE Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
PBE Price CAGR:1Y: 38.13%2Y: 18.77%5Y: 5.84%10Y: 9.87%

PBE Dividend Payments & Yield

Dividend Payments & Yield
PBE Dividend CAGR:1Y: -56.90%2Y: 47.81%5Y: 31.17%10Y: 10.75%
Annual Dividends (Total Paid Per Year)
Dividend Growth Year Over Year

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Compare stocks side-by-side

PBE Dividends Info:

Annual Dividend: $0.076
Forward Yield: 0.08%
Ex-Dividend Date: 2026-09-21
Lifetime Dividends / Share: $3.15

PBE Dividend History: Dates, Payments & Yield list

Below is a schedule of all PBE dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
09/21/202609/23/2026$0.0190.08%0.08%$96.27
06/22/202606/24/2026$0.8113.83%3.71%$87.40
03/23/202603/25/2026$0.0820.43%0.42%$78.07
12/22/202512/24/2025$0.4202.02%2%$84.16
09/22/202509/24/2025$0.2341.33%1.35%$69.14
06/23/202506/25/2025$0.1300.82%0.81%$63.89
03/24/202503/26/2025$0.0340.2%0.21%$64.89
06/24/202406/26/2024$0.0080.05%0.05%$65.27
03/18/202403/20/2024$0.0240.15%0.15%$64.94
06/20/202306/22/2023$0.0140.09%0.09%$62.41
03/23/202003/31/2020$0.0290.07%0.06%$46.49
09/24/201809/28/2018$0.0020%0%$59.45
06/16/201706/30/2017$0.2150.5%0.47%$45.67
03/17/201703/31/2017$0.0560.13%0.13%$42.29
12/16/201612/30/2016$0.1210.29%0.31%$38.81
09/16/201609/30/2016$0.0280.07%0.07%$41.95
12/18/201512/31/2015$0.3080.62%0.61%$50.52
09/18/201509/30/2015$0.1370.25%0.3%$45.72
06/19/201506/30/2015$0.1230.21%0.21%$58.35
09/19/201409/30/2014$0.0430.09%0.09%$46.22
06/20/201406/30/2014$0.2340.53%0.54%$43.71
12/18/200911/30/-0001$0.0760.47%0.47%$16.16

Projected Future Returns & Dividends for PBE

Based on past 10-year performance, here are PBE growth metrics:

Share price CAGR of +9.87%
Dividend CAGR of +10.75%

Using PBE CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

PBE (DRIP)PBE - No DRIP
Current Price$98.93$98.93
Start Shares101.08101.08
Start Value$10,000$10,000
  
After 10 years:
Final Share Count101.89101.08
Dividends Payment$0.05$0.05
Annual Dividends$22$21
Yield on cost0.22%0.21%
Share Price$253.49$253.49
Total Dividends$128$127
Final Value$25,828$25,750

Estimated Future Value + Dividends - PBE

NOTE: Above numbers are our estimate based on PBE's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Invesco Biotechnology & Genome ETF (PBE) had its IPO on 2005-06-23, and is traded on AMEX stock exchange.

The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.

PBE website: https://www.invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF model unavailable for PBE — no fundamentals on file (ETFs and funds are not modelable).